-
1
-
-
66349087952
-
2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment
-
2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. Eur Heart J 2009, 30:1279-1286.
-
(2009)
Eur Heart J
, vol.30
, pp. 1279-1286
-
-
Pulcinelli, F.M.1
Biasucci, L.M.2
Riondino, S.3
-
2
-
-
33244486544
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29:S1-S48.
-
(2006)
Diabetes Care
, vol.29
-
-
-
3
-
-
46049108934
-
Antiplatelet drugs
-
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
Patrono C., Baigent C., Hirsh J., Roth G. Antiplatelet drugs. CHEST 2008, 133:199S-233S. 8th ed.
-
(2008)
CHEST
, vol.133
-
-
Patrono, C.1
Baigent, C.2
Hirsh, J.3
Roth, G.4
-
4
-
-
55449132867
-
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid. Determinants and effect on cardiovascular risk
-
Eikelboom J.W., Hankey G.J., Thom J., et al. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid. Determinants and effect on cardiovascular risk. Circulation 2008, 118:1705-1712.
-
(2008)
Circulation
, vol.118
, pp. 1705-1712
-
-
Eikelboom, J.W.1
Hankey, G.J.2
Thom, J.3
-
5
-
-
77949568986
-
Post interventional cardiology urinary thromboxane correlates with PlateletMapping® detected aspirin resistance
-
Carrol R.C., Worthington R.E., Craft R.M., et al. Post interventional cardiology urinary thromboxane correlates with PlateletMapping® detected aspirin resistance. Thromb Res 2010, 125:e118-e122.
-
(2010)
Thromb Res
, vol.125
-
-
Carrol, R.C.1
Worthington, R.E.2
Craft, R.M.3
-
7
-
-
40749143091
-
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects
-
Formoso G., De Filippis E.A., Michetti N., et al. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects. Diabetes Metab Res Rev 2008, 24:231-237.
-
(2008)
Diabetes Metab Res Rev
, vol.24
, pp. 231-237
-
-
Formoso, G.1
De Filippis, E.A.2
Michetti, N.3
-
8
-
-
0347423198
-
Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
-
Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42:1206-1252.
-
(2003)
Hypertension
, vol.42
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
9
-
-
78650938912
-
Platelet activation in hypertension associated with hypercholesterolemia: effects of irbesartan
-
Alexandru N., Popov D., Dragan E., Andrei E., Georgescu A. Platelet activation in hypertension associated with hypercholesterolemia: effects of irbesartan. J Thromb Haemost 2011, 9:173-184.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 173-184
-
-
Alexandru, N.1
Popov, D.2
Dragan, E.3
Andrei, E.4
Georgescu, A.5
-
10
-
-
77954092698
-
Mean platelet volume in patients with prehypertension and hypertension
-
Varol E., Akcay S., Icli A., et al. Mean platelet volume in patients with prehypertension and hypertension. Clin Hemorheol Microcirc 2010, 45:67-72.
-
(2010)
Clin Hemorheol Microcirc
, vol.45
, pp. 67-72
-
-
Varol, E.1
Akcay, S.2
Icli, A.3
-
11
-
-
33644554181
-
Increased fibrinolysis and platelet activation in elderly patients undergoing coronary bypass surgery
-
Pleym H., Wahba A., Videm V., et al. Increased fibrinolysis and platelet activation in elderly patients undergoing coronary bypass surgery. Anesth Analg 2006, 102:660-667.
-
(2006)
Anesth Analg
, vol.102
, pp. 660-667
-
-
Pleym, H.1
Wahba, A.2
Videm, V.3
-
12
-
-
79957893988
-
Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study
-
Frost-Pineda K., Liang Q., Liu J., et al. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res 2011, 13(3):182-197.
-
(2011)
Nicotine Tob Res
, vol.13
, Issue.3
, pp. 182-197
-
-
Frost-Pineda, K.1
Liang, Q.2
Liu, J.3
-
13
-
-
83855165740
-
Platelet activation in obesity and metabolic syndrome
-
Santilli F., Vazzana N., Liani R., Guagnano M.T., Davì G. Platelet activation in obesity and metabolic syndrome. Obes Rev 2012, 13(1):27-42.
-
(2012)
Obes Rev
, vol.13
, Issue.1
, pp. 27-42
-
-
Santilli, F.1
Vazzana, N.2
Liani, R.3
Guagnano, M.T.4
Davì, G.5
-
14
-
-
30944467297
-
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials
-
Berger J.S., Roncaglioni M.C., Avanzini F., Pangrazzi I., Tognoni G., Brown D.L. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006, 295:306-313.
-
(2006)
JAMA
, vol.295
, pp. 306-313
-
-
Berger, J.S.1
Roncaglioni, M.C.2
Avanzini, F.3
Pangrazzi, I.4
Tognoni, G.5
Brown, D.L.6
-
15
-
-
65549087101
-
Antiplatelet actions of statins and fibrates are mediate by PPARs
-
Ali F.Y., Armstrong P.C., Dhanji A.R., et al. Antiplatelet actions of statins and fibrates are mediate by PPARs. Arterioscler Thromb Vasc Biol 2009, 29:706-711.
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 706-711
-
-
Ali, F.Y.1
Armstrong, P.C.2
Dhanji, A.R.3
|